C4BPA and atherosclerosis: The role and mechanism of C4BPA in atherosclerosis have not been elucidated, but one study has shown that C4BPA expression is a promising biomarker to predict clopidogrel resistance during the treatment of atherosclerosis [34, 35], and clopidogrel is mainly used to prevent and treat diseases related to atherosclerosis and thrombosis.